Obesity in Norway

From WikiMD's WELLNESSPEDIA


Norway, a country located in Europe, had an adult obesity rate of 23.1% in 2016, ranking it 67th globally. This rate is a reflection of the percentage of the adult population in Norway that has a body mass index (BMI) of 30 or higher.

Healthcare in Norway[edit]

Healthcare in Norway is universal and is funded by taxes, along with service fees. The Norwegian healthcare system is primarily public, but there is a small number of private healthcare providers.

Obesity in Norway[edit]

The obesity rate in Norway has been increasing over the years. In 2016, the adult obesity rate was 23.1%, ranking Norway 67th in the world. This is a significant increase from 2000, when the adult obesity rate was 15.5%.

Weight Loss Facilities in Norway[edit]

Norway has several well-known healthcare facilities dedicated to weight loss and obesity treatment. These include:

  • Oslo University Hospital - This hospital has a department dedicated to endocrinology, obesity and preventive medicine. They offer a comprehensive weight loss program that includes dietary counseling, physical activity, and psychological support.
  • Volvat Medical Center - Located in several cities across Norway, Volvat offers a wide range of healthcare services, including weight loss programs and nutritional counseling.
  • Bergen Obesity Research Group - Based at the University of Bergen, this research group is dedicated to studying obesity and developing new treatments and interventions.

See Also[edit]

the World
Countries
Afghanistan / Albania / Algeria / Andorra / Angola / Antigua and Barbuda / Argentina / Armenia / Australia / Austria / Azerbaijan / Bahamas / Bahrain / Bangladesh / Barbados / Belarus / Belgium / Belize / Benin / Bhutan / Bolivia / Bosnia and Herzegovina / Botswana / Brazil / Brunei / Bulgaria / Burkina Faso / Burundi / Cambodia / Cameroon / Canada / Cape Verde / Central African Republic / Chad / Chile / China / Colombia / Comoros / Costa Rica / Croatia / Cuba / Cyprus / Czech Republic / Democratic Republic of the Congo / Denmark / Djibouti / Dominica / Dominican Republic / Ecuador / Egypt / El Salvador / Equatorial Guinea / Eritrea / Estonia / Eswatini / Ethiopia / Federated States of Micronesia / Fiji / Finland / France / Gabon / Gambia / Georgia / Germany / Ghana / Greece / Grenada / Guatemala / Guinea / Guinea-Bissau / Guyana / Haiti / Honduras / Hungary / Iceland / India / Indonesia / Iran / Iraq / Ireland / Israel / Italy / Ivory Coast / Jamaica / Japan / Jordan / Kazakhstan / Kenya / Kiribati / Kosovo / Kuwait / Kyrgyzstan / Laos / Latvia / Lebanon / Lesotho / Liberia / Libya / Liechtenstein / Lithuania / Luxembourg / Madagascar / Malawi / Malaysia / Maldives / Mali / Malta / Marshall Islands / Mauritania / Mauritius / Mexico / Moldova / Monaco / Mongolia / Montenegro / Morocco / Mozambique / Myanmar / Namibia / Nauru / Nepal / Netherlands / New Zealand / Nicaragua / Niger / Nigeria / North Korea / North Macedonia / Norway / Oman / Pakistan / Palau / Palestine / Panama / Papua New Guinea / Paraguay / Peru / Philippines / Poland / Portugal / Qatar / Republic of the Congo / Romania / Russia / Rwanda / Saint Kitts and Nevis / Saint Lucia / Saint Vincent and the Grenadines / Samoa / San Marino / Saudi Arabia / Senegal / Serbia / Seychelles / Sierra Leone / Singapore / Slovakia / Slovenia / Solomon Islands / Somalia / South Africa / South Korea / South Sudan / Spain / Sri Lanka / Sudan / Suriname / Sweden / Switzerland / Syria / São Tomé and Príncipe / Taiwan / Tajikistan / Tanzania / Thailand / Timor-Leste / Togo / Tonga / Trinidad and Tobago / Tunisia / Turkey / Turkmenistan / Tuvalu / Uganda / Ukraine / United Arab Emirates / United Kingdom / United States / Uruguay / Uzbekistan / Vanuatu / Vatican City / Venezuela / Vietnam / Western Sahara / Yemen / Zambia / Zimbabwe


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Obesity_in_Norway&oldid=5162817"